Javier Glez-Vaz

9PUBLICATIONS
42CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 09, 2024
CD137 (4-1BB) and T-Lymphocyte Exhaustion.

Paula Molero-Glez, Arantza Azpilikueta, Laura Mosteo

|Oct 12, 2023
Cytotoxicity as a form of immunogenic cell death leading to efficient tumor antigen cross-priming.

Carlos Luri-Rey, Gabriel Gomis, Javier Glez-Vaz

|Aug 18, 2023
CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects.

Javier Glez-Vaz, Arantza Azpilikueta, María C Ochoa

|Dec 28, 2022
CD137 (4-1BB)-Based Cancer Immunotherapy on Its 25th Anniversary.

Ignacio Melero, Miguel F Sanmamed, Javier Glez-Vaz

|Dec 08, 2022
Intratumoral Gene Transfer of mRNAs Encoding IL12 in Combination with Decoy-Resistant IL18 Improves Local and Systemic Antitumor Immunity.

Assunta Cirella, Elixabet Bolaños, Claudia Augusta Di Trani

|Jun 30, 2022
A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β.

Irene Olivera, Rebeca Sanz-Pamplona, Elixabet Bolaños

Pageof 2